TMS's research team received the German University Medical Award for the GLORIA clinical trial of glioblastoma using NOX-A12. The innovative treatment approach and clinical trial results were highly rated.
TMS's research team received the German University Medical Award for the GLORIA clinical trial of glioblastoma. The award reflects recognition of the treatment using NOX-A12 developed by the research team and the clinical results of the GLORIA trial.
The treatment covered by the award uses NOX-A12, and the results of the clinical trial named GLORIA were evaluated for the award. Details of the specific clinical data are presented in the full article.
The award recognizes TMS's research team's development of a novel treatment approach for glioblastoma and its advancement of clinical trials. Attention is focused on future reporting of results and the status of additional trials.